Invivyd (IVVD) Change in Receivables (2024 - 2025)
Invivyd (IVVD) reported Change in Receivables of $4.1 million for Q4 2025, up 47.82% on a YoY basis from $2.8 million in Q4 2024, and up 199.12% quarter-over-quarter from $1.4 million in Q3 2025.
Invivyd (IVVD) Change in Receivables (2024 - 2025) Analysis & Trends
Invivyd has reported Change in Receivables for 2 years, with the latest figure at $4.1 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Receivables rose 47.82% year-over-year to $4.1 million; the trailing twelve-month figure through Dec 2025 stood at $3.3 million (down 69.4% YoY), and the FY2025 full-year result was $3.3 million, down 69.4% from the prior year.
- Change in Receivables for Q4 2025 stood at $4.1 million, up from $1.4 million in the prior quarter.
- The five-year high for Change in Receivables was $5.3 million in Q3 2024, with the low at -$2.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | 4.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.07 Mn |
| Dec 31, 2025 | 4.07 Mn |
| Sep 30, 2025 | 1.36 Mn |
| Sep 30, 2025 | 1.36 Mn |
| Jun 30, 2025 | 254,000.00 |
| Jun 30, 2025 | 254,000.00 |
| Mar 31, 2025 | -2.35 Mn |
| Mar 31, 2025 | -2.35 Mn |
| Dec 31, 2024 | 2.75 Mn |
| Dec 31, 2024 | 2.75 Mn |
| Sep 30, 2024 | 5.27 Mn |
| Sep 30, 2024 | 5.27 Mn |
| Jun 30, 2024 | 2.89 Mn |
| Jun 30, 2024 | 2.89 Mn |